SQUAMOUS-CELL CARCINOMA OF THE PROSTATE - A TRANSFORMATION FROM ADENOCARCINOMA AFTER THE USE OF A LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST AND FLUTAMIDE

被引：19
|
作者：
BRASLIS, KG
DAVI, RC
NELSON, E
CIVANTOS, F
SOLOWAY, MS
机构：
[1] UNIV MIAMI,SCH MED,DEPT UROL,MIAMI,FL 33101
[2] UNIV MIAMI,SCH MED,DEPT PATHOL,MIAMI,FL 33101
来源：
UROLOGY | 1995年 / 45卷 / 02期
关键词：
D O I：
10.1016/0090-4295(95)80028-X
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
  • [1] Transformation of a prostatic adenocarcinoma into squamous cell carcinoma after luteinizing hormone-releasing hormone (LHRH) agonist and radiotherapy treatment
    Ichaoui, Hamza
    Ben Nasr, Sonia
    Gargouri, Faten
    Zribi, Aref
    Hermi, Amine
    Fendri, Sana
    Balti, Mehdi
    Ayari, Jihen
    Khiari, Ramzi
    Msakni, Issam
    Mansouri, Nada
    Ghozzi, Samir
    Haddaoui, Abderrazek
    PAN AFRICAN MEDICAL JOURNAL, 2019, 34
  • [2] USE OF INTRANASAL LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST IN UTERINE LEIOMYOMAS
    MAHEUX, R
    LEMAY, A
    MERAT, P
    FERTILITY AND STERILITY, 1987, 47 (02) : 229 - 233
  • [3] NATIONAL-CANCER-INSTITUTE STUDY OF LUTEINIZING-HORMONE-RELEASING HORMONE PLUS FLUTAMIDE VERSUS LUTEINIZING-HORMONE-RELEASING HORMONE PLUS PLACEBO
    BENSON, RC
    CRAWFORD, ED
    EISENBERGER, MA
    MCLEOD, DG
    SPAULDING, JT
    DORR, FA
    SEMINARS IN ONCOLOGY, 1991, 18 (05) : 9 - 12
  • [4] LUTEINIZING-HORMONE-RELEASING HORMONE IN PROSTATE-CANCER
    MOTT, JM
    MIWA, LJ
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (06): : 442 - 443
  • [5] STIMULATION OF THE CIRCULATING LEVELS OF GLYCOPROTEIN HORMONE ALPHA-SUBUNIT AFTER COMBINED ADMINISTRATION OF A LUTEINIZING-HORMONE-RELEASING HORMONE (LHRH) AGONIST AND FLUTAMIDE IN PATIENTS WITH CANCER OF THE PROSTATE
    STARNAUD, R
    LACHANCE, R
    DUPONT, A
    LABRIE, F
    CLINICAL AND INVESTIGATIVE MEDICINE, 1986, 9 (04): : 215 - 221
  • [6] LUTEINIZING-HORMONE-RELEASING HORMONE (LHRH) AGONISTS TREATMENT IN METASTATIC PROSTATE CARCINOMA
    GEZ, E
    BIRAN, S
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1988, 24 (08): : 453 - 453
  • [7] RECEPTORS FOR PROLACTIN, SOMATOSTATIN, AND LUTEINIZING-HORMONE-RELEASING HORMONE IN EXPERIMENTAL PROSTATE-CANCER AFTER TREATMENT WITH ANALOGS OF LUTEINIZING-HORMONE-RELEASING HORMONE AND SOMATOSTATIN
    KADAR, T
    REDDING, TW
    BENDAVID, M
    SCHALLY, AV
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (03) : 890 - 894
  • [8] UTILIZATION OF LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST IN PULMONARY LEIOMYOMATOSIS
    MAHEUX, R
    SAMSON, Y
    FARID, NR
    PARENT, JG
    JEAN, C
    FERTILITY AND STERILITY, 1987, 48 (02) : 315 - 317
  • [9] SUDDEN-DEATH DUE TO DISEASE FLARE WITH LUTEINIZING-HORMONE-RELEASING HORMONE AGONIST THERAPY FOR CARCINOMA OF THE PROSTATE
    THOMPSON, IM
    ZEIDMAN, EJ
    RODRIGUEZ, FR
    JOURNAL OF UROLOGY, 1990, 144 (06): : 1479 - 1480
  • [10] PROSTATE CARCINOMA TUMOR SIZE IN RATS DECREASES AFTER ADMINISTRATION OF ANTAGONISTS OF LUTEINIZING-HORMONE-RELEASING HORMONE
    REDDING, TW
    COY, DH
    SCHALLY, AV
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (04): : 1273 - 1276
12345